Trimedyne, Inc. reported earnings results for the third quarter and nine months ended June 30, 2019. For the quarter ended June 30, 2019, Trimedyne had revenues of $1,017,000, a decrease of 36% from revenues of $1,597,000 for the prior year quarter. The net loss for the current quarter of $136,000 or $1.11 per share, as compared to a net income of $46,000 or $0.38 per share for the prior year quarter. Revenues for the nine-month period ended June 30, 2019, were $3,601,000, a decrease of 20% from revenues of $4,483,000 for the prior year nine-month period. The net loss for the current nine-month period was $260,000 or $2.12 per share, as compared to net income of $156,000 or $1.27 per share for the prior year nine-month period.